How Long Does It Take for HIV to Progress to AIDS in Infected Newborns?

Children born with HIV—known as perinatally acquired HIV infection—typically progress to AIDS more rapidly than adults if left untreated. Without antiretroviral therapy (ART), approximately 25–30% of infected infants develop severe immunodeficiency or AIDS-defining illnesses within the first year of life. A further 50–60% progress to AIDS by age two, and nearly all untreated children will meet clinical or immunologic criteria for AIDS by age five.

This accelerated disease progression reflects several biological factors: immature immune systems, high viral replication rates, rapid CD4+ T-cell decline, and limited capacity to mount effective antiviral responses. In contrast, adults with HIV may remain asymptomatic for a decade or longer without treatment.

Early diagnosis and immediate initiation of ART are critical. When started within the first weeks or months of life, modern combination antiretroviral regimens can suppress viral replication, preserve immune function, and dramatically reduce morbidity and mortality. With timely and sustained treatment, many children achieve long-term viral suppression, normal growth and development, and near-normal life expectancy.

Universal HIV screening of pregnant individuals—and prompt infant testing using virologic assays (e.g., HIV DNA PCR) within the first 48 hours of life in high-risk cases—is essential to identify infection early. Confirmatory testing and ART initiation should occur no later than two weeks of age for diagnosed infants, per current WHO and U.S. DHHS guidelines.